1. Home
  2. KLTO vs SLE Comparison

KLTO vs SLE Comparison

Compare KLTO & SLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • SLE
  • Stock Information
  • Founded
  • KLTO 2019
  • SLE 2014
  • Country
  • KLTO United States
  • SLE United States
  • Employees
  • KLTO N/A
  • SLE N/A
  • Industry
  • KLTO
  • SLE Services-Misc. Amusement & Recreation
  • Sector
  • KLTO
  • SLE Consumer Discretionary
  • Exchange
  • KLTO NYSE
  • SLE Nasdaq
  • Market Cap
  • KLTO 5.9M
  • SLE 6.5M
  • IPO Year
  • KLTO N/A
  • SLE 2019
  • Fundamental
  • Price
  • KLTO $1.34
  • SLE $5.82
  • Analyst Decision
  • KLTO
  • SLE Strong Buy
  • Analyst Count
  • KLTO 0
  • SLE 2
  • Target Price
  • KLTO N/A
  • SLE $100.00
  • AVG Volume (30 Days)
  • KLTO 22.5M
  • SLE 157.3K
  • Earning Date
  • KLTO 08-15-2025
  • SLE 08-13-2025
  • Dividend Yield
  • KLTO N/A
  • SLE N/A
  • EPS Growth
  • KLTO N/A
  • SLE N/A
  • EPS
  • KLTO N/A
  • SLE N/A
  • Revenue
  • KLTO N/A
  • SLE $14,691,000.00
  • Revenue This Year
  • KLTO N/A
  • SLE N/A
  • Revenue Next Year
  • KLTO N/A
  • SLE $30.36
  • P/E Ratio
  • KLTO N/A
  • SLE N/A
  • Revenue Growth
  • KLTO N/A
  • SLE N/A
  • 52 Week Low
  • KLTO $0.11
  • SLE $3.91
  • 52 Week High
  • KLTO $3.91
  • SLE $65.60
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • SLE 51.50
  • Support Level
  • KLTO N/A
  • SLE $4.71
  • Resistance Level
  • KLTO N/A
  • SLE $6.81
  • Average True Range (ATR)
  • KLTO 0.00
  • SLE 0.65
  • MACD
  • KLTO 0.00
  • SLE 0.34
  • Stochastic Oscillator
  • KLTO 0.00
  • SLE 65.86

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

Share on Social Networks: